About Us

Enlyte News

There’s always something going on at Enlyte. Stay up to date with the latest developments.

Filters
clear all
Filters
Topics
Industry
Type
Brand
Date
Workers' Comp News Release

South Carolina Approves Fee Schedule Changes

The South Carolina Workers’ Compensation Commission approved changes to the Medical Services Provider Manual, effective April 1, 2022. The changes adopted include differences in the proposed rules for pharmacy released by the Commission in December 2021.

Workers' Comp News Release

South Carolina Approves Fee Schedule Changes

The South Carolina Workers’ Compensation Commission approved changes to the Medical Services Provider Manual, effective April 1, 2022. The changes adopted include differences in the proposed rules for pharmacy released by the Commission in December 2021. One of the biggest changes from the proposed rule to the adopted language involved prescription topical medications. The new reimbursement rule for non-compound prescription topical medications is $240 for a 30-day supply, pro-rated based on the number of day supply dispensed, not to exceed 90 days, plus a single dispensing fee of $5.

mitchell News Release

Mitchell Introduces New Commercial Truck Estimating Solution

Insurers and repairers can now use Mitchell’s cloud-based technology for appraisals of collision-damaged passenger and specialty vehicles, motorcycles, and light-, medium- and heavy-duty trucks SAN DIEGO, Calif.—Mitchell, an Enlyte company and leading technology and information provider for the Property & Casualty (P&C) claims and Collision Repair industries, today introduced

Workers' Comp In the News

Melissa McGarry: The Great Resignation – Four Ways a Specialty Network Can Help Fill the Talent Gap

Business Insurance: “Drug Formularies Not a Top Legislative Priority this Year” News Release

Business Insurance: “Drug Formularies Not a Top Legislative Priority this Year”

Workers' Comp News Release

Enlyte Publishes 2022 Workers’ Compensation Technology Trends Report

Electronic payment integration, mobile communication for injured employees remain payer priorities

Mitchell News Release

Symbicort Generic Approval on March 15, 2022

Recently the U.S. Food and Drug Administration (FDA) approved a generic formulation of Symbicort metered-dose inhaler for the treatment of asthma or chronic obstructive pulmonary disease (COPD).

Media Kit

Access the Enlyte Media Kit

Media Kit
Media Coverage

See Why Enlyte Keeps Making Headlines

Read More
Enlyte Insights

See the P&C Industry From Our 360-Degree Vantage Point

In an ever-changing landscape, trusted knowledge is like gold. We’re the insiders you can count on to break down the opportunities and challenges facing the industry today, with the expertise to share actionable insights.

Read More
Managing employee injuries
Newsletter

Sign up to Learn More